INS and Hypoglycemia: During a glucose tolerance test (GTT) at 2 weeks post-injection, mice exposed to 200 μg/kg TCDD showed severe hypoglycemia (Fig. 1D) and a dramatic decrease in plasma insulin levels (Fig. 1E).